Loading...

Harrow Health, Inc. 11.875% Senior Notes due 2027

HROWMNASDAQ
HealthcareMedical - Pharmaceuticals
$25.98
$-0.06(-0.21%)

Harrow Health, Inc. 11.875% Senior Notes due 2027 (HROWM) Quarterly Earnings Reports & Financial Results

Analyze Harrow Health, Inc. 11.875% Senior Notes due 2027’s revenue, EPS, and earnings surprises to assess performance and investor sentiment over recent quarters.

Total Reports
0
Avg EPS
N/A
Avg Revenue
N/A
Beats Estimates
0 out of 0
Max EPS
N/A
Min EPS
N/A

Earnings Visualization

Visual comparison of Harrow Health, Inc. 11.875% Senior Notes due 2027’s actual vs. estimated earnings across recent quarters.

No data available

Harrow Health, Inc. 11.875% Senior Notes due 2027 (HROWM) Quarterly Earnings Details

Detailed breakdown of Harrow Health, Inc. 11.875% Senior Notes due 2027’s earnings per share (EPS), revenue estimates vs. actuals, and earnings surprises by quarter.

Frequently Asked Questions